UA96575C2 - Process for the preparation of olmesartan medoxomil - Google Patents

Process for the preparation of olmesartan medoxomil

Info

Publication number
UA96575C2
UA96575C2 UAA200801032A UAA200801032A UA96575C2 UA 96575 C2 UA96575 C2 UA 96575C2 UA A200801032 A UAA200801032 A UA A200801032A UA A200801032 A UAA200801032 A UA A200801032A UA 96575 C2 UA96575 C2 UA 96575C2
Authority
UA
Ukraine
Prior art keywords
preparation
olmesartan medoxomil
olmesartan
hypertension
medicament
Prior art date
Application number
UAA200801032A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Силво Жупанчич
Аника Пекавар
Миха Врбинц
Рената Осолник
Original Assignee
Крка Товарная Здравил, Д.Д. Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка Товарная Здравил, Д.Д. Ново Место filed Critical Крка Товарная Здравил, Д.Д. Ново Место
Publication of UA96575C2 publication Critical patent/UA96575C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to an improved process for the manufacture of olmesartan and pharmaceutically acceptable salts and esters thereof as an active ingredient of a medicament for the treatment of hypertension and related diseases and conditions.
UAA200801032A 2005-07-29 2006-07-27 Process for the preparation of olmesartan medoxomil UA96575C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200500221A SI22092A (en) 2005-07-29 2005-07-29 Procedure for preparation of olmertsan medoximil

Publications (1)

Publication Number Publication Date
UA96575C2 true UA96575C2 (en) 2011-11-25

Family

ID=37774952

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200801032A UA96575C2 (en) 2005-07-29 2006-07-27 Process for the preparation of olmesartan medoxomil

Country Status (3)

Country Link
CN (1) CN101238119A (en)
SI (1) SI22092A (en)
UA (1) UA96575C2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009151016A1 (en) 2008-06-09 2009-12-17 第一三共株式会社 Method for producing 1-biphenylmethylimidazole compound
KR20120006513A (en) 2009-04-28 2012-01-18 다이이찌 산쿄 가부시키가이샤 Novel solvate crystals
CN102414200B (en) 2009-04-28 2014-12-17 第一三共株式会社 Method for producing olmesartan medoxomil
CN102050816A (en) * 2009-10-28 2011-05-11 北京万全阳光医学技术有限公司 Method for synthesizing olmesartan medoxomil
CN102206208A (en) * 2010-12-24 2011-10-05 上海现代制药股份有限公司 Preparation method for olmensartan medoxomil with low-level impurity
CN102558161B (en) * 2011-12-07 2016-07-06 浙江华海药业股份有限公司 A kind of technique adopting the refining olmesartan medoxomil of acetone and water mixed liquid
CN103880825B (en) * 2014-03-14 2019-03-05 浙江华海药业股份有限公司 A kind of preparation process of high-purity trityl olmesartan medoxomil
CN104447715B (en) * 2014-11-28 2017-06-20 山东新华制药股份有限公司 The preparation method of olmesartan medoxomil
CN107311990B (en) * 2017-07-25 2021-09-03 浙江华海致诚药业有限公司 Preparation method of olmesartan medoxomil
CN109761966A (en) * 2019-01-30 2019-05-17 浙江省食品药品检验研究院 A kind of Olmesartan medoxomil crystal and preparation method thereof
CN112321575B (en) * 2020-11-18 2023-07-21 福建天泉药业股份有限公司 Olmesartan medoxomil refining method suitable for industrial production
CN115887393B (en) * 2022-10-31 2024-05-24 修正药业集团股份有限公司 Olmesartan medoxomil tablet and preparation method thereof

Also Published As

Publication number Publication date
CN101238119A (en) 2008-08-06
SI22092A (en) 2007-02-28

Similar Documents

Publication Publication Date Title
WO2007017135A3 (en) Process for the preparation of olmesartan medoxomil
UA96575C2 (en) Process for the preparation of olmesartan medoxomil
WO2007003330A3 (en) Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist
AR047993A1 (en) PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES
IN2012DN02465A (en)
UA90545C2 (en) Solid orally administerable pharmaceutical dosage forms with rapid release of inhibitor of coagulation factor xa
AU2012243329A8 (en) 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use
UA110013C2 (en) APPLICATION OF THE COMPOSITION FOR THE TREATMENT OF BALL-MARI-HERE AND THE RELATED DISORDERS
MD20140059A2 (en) Substituted 4-phenyl-pyridines for the treatment of NK-1 receptor related diseases
NZ589764A (en) NMDA receptor antagonists for the treatment of neuropsychiatric disorders
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MX2009006764A (en) Bicyclic pyrimidinones and uses thereof.
WO2009109616A8 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
WO2011023367A3 (en) Bisphosphonate-prodrugs
NZ597866A (en) Therapeutic lactams
MX2009007040A (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension.
SG141358A1 (en) Treatment of psychiatric patients with reduced heptaic function with paliperidone
UA95274C2 (en) Solid pharmaceutical composition comprising irbesartan and processes for the manufacture thereof
WO2007134085A3 (en) Isothiazolidines useful in the treatment of ocular hypertensive conditions
NO20082140L (en) Process for making candesartan lexile
WO2010048452A3 (en) Polycyclic compounds and methods related thereto
SG10201809506TA (en) Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
WO2010013925A3 (en) Pharmacological composition for prevention and treatment of respiratory disease containing pyrazolopyrimidinone compound or pharmaceutically acceptable salts thereof